首页>
外国专利>
METHOD FOR EVALUATING THE EFFICIENCY treatment of latent Crohn's disease in children ileocecal localization
METHOD FOR EVALUATING THE EFFICIENCY treatment of latent Crohn's disease in children ileocecal localization
展开▼
机译:评估儿童回盲盲区隐性克罗恩病治疗效率的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
a way to evaluate the effectiveness of u043bu0435u0447u0435u043du0438u00a0 latent forms of crohn's disease u0438u043bu0435u043eu0446u0435u043au0430u043bu044cu043du043eu0439 localization in children with common clinical and laboratory examination of u0442u043bu0438u0447u0430u044eu0449u0438u0439u0441u00a0, further u043fu0440u043eu0432u043eu0434u00a0u0442 u0440u0435u0442u0440u043eu0433u0440u0430u0434u043du0443u044e u0438u043bu0435u043eu0441u043au043eu043fu0438u044e and u043cu043eu0440u0444u043eu043cu0435u0442u0440u0438u0447u0435u0441u043au043eu0435 study u0441u043eu0441u0442u043eu00a0u043du0438u00a0 u043cu0438u043au0440u043eu0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0433u043e channel.in u0431u0438u043eu043fu0442u0430u0442u0435 ileum mucosa colon u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 number of vessels and the u043cu0438u043au0440u043eu0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0433u043e channel, u00a0u0434u0435u0440u043du043e - u0446u0438u0442u043eu043fu043bu0430u0437u043cu0430u0442u0438u0447u0435u0441u043au043eu0435 u0441u043eu043eu0442u043du043eu0448u0435 the endothelial cells u043cu0438u043au0440u043eu0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0433u043e channel and an average diameter of vessel duct before and in the process of u043bu0435u0447u0435u043du0438u00a0 not earlier than in 0.5 years from the commencement of the drugs and with a dramatic reduction in the number of receptacles in the form of u0430u043du0433u0438u043eu0433u0435u043du0435u0437u0430 u0443u043cu0435u043du044cu0448u0435u043du0438u00a0 525%, u0441u043eu043au0440u0430u0449u0435u043du0438u00a0 square u043cu0438u043au0440u043eu0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0433u043e channel n a 2415% and u0443u0432u0435u043bu0438u0447u0435u043du0438u00a0 u00a0u0434u0435u0440u043du043e - u0446u0438u0442u043eu043fu043bu0430u0437u043cu0430u0442u0438u0447u0435u0441u043au043eu0433u043e u0441u043eu043eu0442u043du043eu0448u0435u043du0438u00a0 in endothelial cells u043cu0438u043au0440u043eu0446u0438u0440u043au0443u043bu00a0u0442u043eu0440u043du043eu0433u043e channel in 2 times.expression of reduction of their u043fu043eu0432u0440u0435u0436u0434u0435u043du0438u00a0 and u0443u0432u0435u043bu0438u0447u0435u043du0438u00a0 medium diameter vessel duct at 408%, coupled with the reduction of edema and infiltration of u043fu0435u0440u0438u0432u0430u0441 u043au0443u043bu00a0u0440u043du044bu0445 spaces in the u044du043au0441u0443u0434u0430u0446u0438u0438 in tissue u0441u0443u0434u00a0u0442 of reliable performance u043bu0435u0447u0435u043du0438u00a0.
展开▼